Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roscoe

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|September 6, 2005
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialKishan J Pandya, Gary R Morrow, Joseph A Roscoe, et al.
The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.
Journal of Pain and Symptom Management|August 9, 2003
The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter studyJoseph A Roscoe, Gary R Morrow, Jane T Hickok, et al.
Cancer|July 3, 1999
Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settingsJ T Hickok, J A Roscoe, G R Morrow, et al.
Journal of Psychosomatic Research|November 29, 2011
Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapyJoseph A Roscoe, Michael L Perlis, Wilfred R Pigeon, et al.
Treatment Strategies. Oncology|February 6, 2015
A Brief Patient Self-Report Screening Measure of Cancer Treatment-Related Memory Problems: Latent Structure and Reliability AnalysisPascal Jean-Pierre, Gary R Morrow, Supriya G Mohile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology ProgramOxana G Palesh, Joseph A Roscoe, Karen M Mustian, et al.
Sleep Medicine|June 19, 2016
Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivorsSheila N Garland, Joseph A Roscoe, Charles E Heckler, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 22, 2016
Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research ProgramMatthew Asare, Luke J Peppone, Joseph A Roscoe, et al.
Behavioral Sleep Medicine|January 28, 2017
Social Support, Insomnia, and Adherence to Cognitive Behavioral Therapy for Insomnia After Cancer TreatmentCharles Kamen, Sheila N Garland, Charles E Heckler, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|September 6, 2005
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialKishan J Pandya, Gary R Morrow, Joseph A Roscoe, et al.
The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.
Journal of Pain and Symptom Management|August 9, 2003
The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter studyJoseph A Roscoe, Gary R Morrow, Jane T Hickok, et al.
Cancer|July 3, 1999
Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settingsJ T Hickok, J A Roscoe, G R Morrow, et al.
Journal of Psychosomatic Research|November 29, 2011
Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapyJoseph A Roscoe, Michael L Perlis, Wilfred R Pigeon, et al.
Treatment Strategies. Oncology|February 6, 2015
A Brief Patient Self-Report Screening Measure of Cancer Treatment-Related Memory Problems: Latent Structure and Reliability AnalysisPascal Jean-Pierre, Gary R Morrow, Supriya G Mohile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology ProgramOxana G Palesh, Joseph A Roscoe, Karen M Mustian, et al.
Sleep Medicine|June 19, 2016
Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivorsSheila N Garland, Joseph A Roscoe, Charles E Heckler, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 22, 2016
Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research ProgramMatthew Asare, Luke J Peppone, Joseph A Roscoe, et al.
Behavioral Sleep Medicine|January 28, 2017
Social Support, Insomnia, and Adherence to Cognitive Behavioral Therapy for Insomnia After Cancer TreatmentCharles Kamen, Sheila N Garland, Charles E Heckler, et al.
Pageof 13